在循环瘤细胞中KRAS突变和CTLA-4mRNA表达之间的相关性:结肠直肠癌的临床影响
Sharmin Aktar1,2,3, Farhadul Islam4, Tracie Cheng1,2
1Cancer Molecular Pathology, School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
Genes
|September 28, 2023
概括
循环瘤细胞 (CTC) 中的KRAS突变与较差的结直肠癌 (CRC) 结果有关,并可能影响免疫治疗反应. 在CTC中评估KRAS提供了对癌症癌症的实时见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 晚期或复发性结直肠癌 (CRC) 治疗可能受益于涉及KRAS抑制和免疫治疗的组合策略.
- 在循环瘤细胞 (CTC) 中评估KRAS突变对于优化CRC的临床结果至关重要.
研究的目的:
- 为了研究CTC和匹配的CRC组织中的KRAS基因组变异.
- 为了比较KRAS和CTLA-4mRNA表达在野生类型与KRAS突变的CTC和CRC组织.
- 为了将KRAS突变与CRC患者的临床病理特征相关联.
主要方法:
- 从CTC和CRC组织中提取基因组DNA.
- 使用测序识别KRAS突变的12和13编码子.
- 对KRAS和CTLA-4mRNA表达的定量实时PCR分析.
- 对临床病理学相关性的统计分析.
主要成果:
- 鉴定了6种KRAS突变;16.7%的CTC和65.2%的CRC组织存在突变.
- 在CTC中KRAS变异不同于匹配的瘤组织.
- 在KRAS突变样本中观察到更高的CTLA-4mRNA表达,尽管在统计学上不显著.
- 在CTC中KRAS突变与差异化瘤,淋巴结转移,围神经入侵和晚期病理阶段相关.
结论:
- 在CTC中KRAS突变与CRC中的侵略性临床病理特征有关.
- CTC提供了一个实时平台,用于评估KRAS突变和潜在的免疫治疗点.
- 癌细胞异质性,如CTC分析所示,对于理解克隆动态很重要.
相关概念视频
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K